MLTX
MoonLake Immunotherapeutics
11.70$
+2.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | |
| – | 0.00 | 0.00 | 0.00 | -0.02 | -0.04 | |
| – | 0.96 | 1.43 | 0.65 | 1.79 | 3.15 | |
| – | 0.12 | 0.78 | 0.45 | 0.48 | 0.65 | |
| 0.01 | 0.12 | 2.22 | 1.10 | 2.28 | 3.76 | |
| -0.01 | -0.12 | -2.22 | -1.10 | -2.28 | -3.80 | |
| – | 0.00 | 0.02 | 0.00 | 0.00 | 0.11 | |
| -0.01 | -0.12 | -2.20 | -0.90 | -1.92 | -3.56 | |
| -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| -0.01 | -0.12 | -2.20 | -0.73 | -1.89 | -3.53 | |
| -0.01 | -0.12 | -2.22 | -0.89 | -1.90 | -3.41 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.